Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AURA US Equity

Aura Biosciences, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1501796 · FY ends Dec 31
$7.79
-0.37 (-4.53%)
USD · as of 2026-08-19 · marketstack
10 8-K filings · 1 13D · 8 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Frazier Life Sciences Public Fund, L.P.sec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Long Focus Capital Management, LLCsec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-08-118-K 8.01Other eventssec.gov ↗
2026-08-118-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-118-K 2.05Costs associated with exit or disposal activities (restructuring)sec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-058-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-088-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-06-118-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-1213GSchedule 13G filed — ≥5% beneficial owner (passive) · by TCG Crossover GP II, LLCsec.gov ↗
2026-05-1113D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Matrix Capital Management Company, LPsec.gov ↗
2026-05-118-K 8.01Other eventssec.gov ↗
2026-05-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-058-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-048-K 8.01Other eventssec.gov ↗
2026-05-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-048-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-048-K 8.01Other eventssec.gov ↗
2026-05-048-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-308-K 8.01Other eventssec.gov ↗
2026-03-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Advent Life Sciences LLPsec.gov ↗
2026-02-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Frazier Life Sciences Public Fund, L.P.sec.gov ↗
2025-11-138-K 8.01Other eventssec.gov ↗
2025-11-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-1713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-17

Every row is a filed document, checked against its EDGAR index.